Ovid Therapeutics Inc. ·

OVID 8-K 2026-08-13

Ovid Therapeutics Inc. (OVID) 8-K dated 2026-08-13 — accession 0001628280-26-056497. This URL is the filing, not the OVID hub.

Ovid Therapeutics Inc. (OVID) is a biotechnology company listed on US.

Ovid Therapeutics Inc. filed a 8-K on 2026-08-13. Accession 0001628280-26-056497.

Cached items: 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.

Not investment advice. The OVID SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR